Comprehensive Guide to Managing Blood Glucose Levels (hyperglycemia and hypoglycemia) with Regular Insulin and 50% Glucose 50 mL aka. RI Scale

The Table of RI Scale

This table provides a clear and concise reference for managing different DTX levels and includes the dosing schedule for Metformin in adults.

---

The RI Scale by DTX for Hyperglycemia Management

DTX Levels and Management Instructions:

1. DTX < 80 mg/dL:
   • Management: Administer 50% Glucose 50 mL IV.
   • Note: This is for managing hypoglycemia (low blood sugar).
2. DTX 181 - 200 mg/dL:
   • Management: Administer RI 2 units subcutaneously (sc).
3. DTX 201 - 250 mg/dL:
   • Management: Administer RI 4 units sc.
4. DTX 251 - 300 mg/dL:
   • Management: Administer RI 6 units sc.
5. DTX 301 - 350 mg/dL:
   • Management: Administer RI 8 units sc.
6. DTX > 350 mg/dL:
   • Management: Administer RI 10 units sc.

Notes:

• Serial DTX Measurement: This protocol applies specifically to patients who require serial DTX measurements, not those receiving continuous RI drip or those adjusting their glucose levels with other interventions.
• High DTX Protocol: In cases of very high DTX levels, blood sugar should be measured and sent to the laboratory for verification each time insulin is administered.

Practical Implementation

1. Monitor DTX Regularly: Measure the patient's blood glucose levels regularly, especially in a hospital setting where fluctuations can be critical.
2. Administer Insulin as Indicated: Based on the measured DTX, administer the corresponding units of Regular Insulin subcutaneously.
3. Recheck Blood Glucose: After administering insulin, recheck the blood glucose levels to ensure that they are within the desired range and adjust the management plan as necessary.

---

Regular Insulin (RI): Mechanism of Action and Dosing Guidelines

Mechanism of Action:

• Regular Insulin (RI) is a short-acting insulin that helps to lower blood glucose levels by facilitating the uptake of glucose into muscle and fat cells and inhibiting the production of glucose by the liver.
• It mimics the body's natural insulin response after a meal, promoting the storage of glucose as glycogen in the liver and muscle and stopping the liver from producing more glucose.

Pharmacokinetics:

• Onset of Action: Approximately 30 minutes after subcutaneous injection.
• Peak Action: 2-4 hours.
• Duration of Action: 6-8 hours.

Dosing Guidelines for Regular Insulin (RI):

General Principles:

• The dose of Regular Insulin should be individualized based on the patient's needs, blood glucose monitoring results, and the target blood glucose levels.
• Regular Insulin can be used alone or in combination with intermediate- or long-acting insulins.

Initial Dosing:

• Type 1 Diabetes: The typical initial total daily insulin dose ranges from 0.4 to 0.5 units/kg body weight, split between basal (long-acting) and prandial (mealtime) insulin.
• Type 2 Diabetes: Patients may start with a lower dose, typically around 0.2 to 0.3 units/kg body weight, due to residual endogenous insulin production.

Adjusting the Dose:

• Doses are adjusted based on blood glucose levels and the patient's response. Common practice is to adjust the dose by 1-2 units at a time, depending on the results of blood glucose monitoring.
• Pre-meal Dosing: The dose of Regular Insulin before meals can be adjusted based on the carbohydrate content of the meal, pre-meal blood glucose level, and activity level.

Example Dosing Schedules:

1. Fixed-Dose Schedule: Consistent dose given at the same times each day, often used in patients with stable and predictable blood glucose levels.
2. Sliding Scale Insulin Therapy (SSI): The dose varies based on pre-meal blood glucose levels. This method is often used in hospital settings.
3. Carbohydrate Counting: Doses are adjusted based on the grams of carbohydrates consumed, with specific insulin-to-carbohydrate ratios (e.g., 1 unit of insulin per 10 grams of carbohydrates).

Practical Implementation:

1. Administering Regular Insulin:
   • Before Meals: Regular Insulin is typically administered 30 minutes before meals to allow it to start working as the blood glucose levels begin to rise after eating.
   • Frequency: Depending on the patient's needs, Regular Insulin may be given 2-3 times daily before meals.
   • Injection Sites: Common injection sites include the abdomen, thigh, and upper arm. Rotating the injection site is important to avoid lipodystrophy (abnormal fat distribution).
2. Monitoring:
   • Blood Glucose Monitoring: Patients should monitor their blood glucose levels regularly, especially before meals and at bedtime.
   • HbA1c: Glycated hemoglobin (HbA1c) levels should be checked every 3-6 months to assess overall blood glucose control over time.

---

Another formula Table: Regular Insulin Sliding Scale Regimens

Regimen Descriptions and Usage

1. Regimen 1 (Elderly or Reduced Renal Function)
   • Indication: Designed for patients over 70 years old or those with a glomerular filtration rate (GFR) less than 50 mL/min/1.73 m².
   • Dosing Strategy: Lower insulin doses to minimize the risk of hypoglycemia due to age-related insulin sensitivity and reduced renal clearance.
2. Regimen 2 (General Population)
   • Indication: Appropriate for most patients without specific risk factors such as extreme age or significant renal impairment.
   • Dosing Strategy: Standard insulin doses based on blood glucose levels, suitable for a wide range of patients.
3. Regimen 3 (High BMI, High Insulin Requirement, or Steroid Use)
   • Indication: Used for patients with a body mass index (BMI) greater than 35, those requiring a total daily insulin dose greater than 80 units, or those on high-dose steroids (prednisolone > 20 mg/day).
   • Dosing Strategy: Higher insulin doses to compensate for increased insulin resistance and the effects of steroids.

Guidelines for Use

• Monitoring: Regular monitoring of blood glucose levels is essential to adjust insulin dosing promptly and avoid complications.
• Adjustments: Adjust doses based on blood glucose readings and patient response. Always consider individual factors such as changes in diet, activity level, or other medications that may affect glucose levels.
• Hypoglycemia Management: For DTX levels below 80 mg/dL, administer 50% glucose 50 mL IV and recheck glucose levels after 30 minutes.
• Severe Hyperglycemia: If DTX exceeds 400 mg/dL, administer the appropriate insulin dose per the sliding scale and notify a healthcare provider immediately.

Conclusion

Effective diabetes management using the RI sliding scale requires personalized care tailored to each patient's unique needs. This guide provides a comprehensive overview of different regimens, enabling healthcare professionals to select the most appropriate insulin dosing strategy based on specific patient characteristics. Continuous monitoring and timely adjustments are crucial to achieving optimal blood glucose control and preventing both short-term and long-term complications.

---

Metformin: Mechanism of Action and Dosing Guidelines

Mechanism of Action:

• Metformin primarily works by inhibiting hepatic glucose production (gluconeogenesis) and improving insulin sensitivity, which increases peripheral glucose uptake and utilization.
• It also decreases the absorption of glucose from the gastrointestinal tract.

Dosing Guidelines for Type 2 Diabetes Mellitus:

Children ≥ 10 Years:

• Starting Dose: 500 mg twice daily. Adjust by increasing 500 mg weekly to a maximum of 2000 mg/day divided every 12 hours.
• Alternative Starting Dose: 250 mg once daily for 3-4 days, then increase to 250 mg twice daily, adjusting gradually to a maximum of 2000 mg/day divided every 12 hours.

Adults:

• Initial Dose: 500 mg twice daily or 850 mg once daily. Adjust by increasing 500 mg weekly or 850 mg every two weeks.
• Possible Adjustment: Some patients may switch to 850 mg twice daily after two weeks of 500 mg twice daily.
• Maximum Dose: 2550 mg/day. For doses higher than 2000 mg/day, divide into three doses daily.

Special Considerations:

1. Contrast Media Exposure:
   • Discontinue metformin on the day of and before receiving contrast media in patients with:
     • eGFR 30-60 mL/min/1.73 m²
     • Liver disease or alcoholism
     • Heart failure
     • Receiving intra-arterial iodinated contrast
   • Restart metformin after 48 hours post-procedure if renal function is stable.
2. Stress Conditions (e.g., fever, trauma, infection, surgery):
   • Temporarily stop metformin to manage blood glucose levels and restart once the stress condition resolves.
3. Renal Impairment:
   • eGFR falls < 45 mL/min/1.73 m²: Assess benefit/risk.
   • eGFR 30-45 mL/min/1.73 m²: Max 1000 mg/day.
   • eGFR < 30 mL/min/1.73 m²: Discontinue metformin.
4. Liver Disease:
   • Not recommended due to the risk of lactic acidosis (MALA).

Formulations:

• Tablets: 500 mg, 850 mg (e.g., Glucophage®)

Example Doses for Oral Administration:

• 500 mg twice daily
• 1x1: 500 mg once daily
• 1x2: 500 mg twice daily
• 1x3: 500 mg three times daily
• 2x2: 1000 mg twice daily

Key Points:

• Metformin should not exceed 2000 mg/day in patients with eGFR 30-45 mL/min/1.73 m².
• Metformin is contraindicated in patients with eGFR < 30 mL/min/1.73 m².
• Adjust doses gradually to minimize gastrointestinal side effects.
• Regular monitoring of renal function is essential when using metformin.

---

Conclusion

This guide provides a clear reference for managing blood glucose levels using the RI scale for different DTX levels and administering Metformin in adults. Regular Insulin (RI) is used to lower blood glucose by enhancing glucose uptake and inhibiting liver glucose production, with doses adjusted based on DTX levels and patient response. Metformin improves insulin sensitivity and reduces hepatic glucose production, with specific dosing guidelines for children and adults, considering factors like renal function and stress conditions. Proper monitoring and individualized dosing are crucial for effective diabetes management.